Effect of liver-directed IFN-γ gene delivery in chronic hepatitis C virus infection

被引：0
|
作者：
Shin, EC
Protzer, U
Untergasser, A
Hasselschwert, D
Rice, CM
Feinstone, SM
Rehermann, B
机构：
[1] NIDDK, Liver Dis Sect, NIH, Bethesda, MD 20892 USA
[2] Univ Cologne, Ctr Mol Med, Cologne, Germany
[3] Univ Louisiana, New Iberia Res Ctr, Lafayette, LA USA
[4] Rockefeller Univ, Ctr Study Hepatitis C, New York, NY USA
[5] US FDA, Ctr Biol Evaluat & Res, Lab Hepatitis Viruses, Bethesda, MD USA
来源：
FASEB JOURNAL | 2004年 / 18卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：A91 / A92
页数：2
相关论文
共 50 条
  • [1] Liver-directed gamma interferon gene delivery in chronic hepatitis C
    Shin, EC
    Protzer, U
    Untergasser, A
    Feinstone, SM
    Rice, CM
    Hasselschwert, D
    Rehermann, B
    JOURNAL OF VIROLOGY, 2005, 79 (21) : 13412 - 13420
  • [2] LIVER-DIRECTED GENE DELIVERY
    WU, GY
    WU, CH
    ADVANCED DRUG DELIVERY REVIEWS, 1993, 12 (03) : 159 - 167
  • [3] EFFECT OF IFN-β FOR PATIENTS WITH CHRONIC HEPATITIS C DISCONTINUING IFN-α THERAPY
    Shimada, Masahiko
    Yoshida, Shuhei
    Kitamuro, Yoshiaki
    Yoshino, Morihiko
    Yomoda, Masoyoshi
    Tsuchishima, Mutsumi
    Kawahara, Hiromu
    Takase, Shujiro
    HEPATOLOGY, 2008, 48 (04) : 883A - 883A
  • [4] OPTIMIZATION OF LIVER-DIRECTED RETROVIRAL GENE DELIVERY
    HAFENRICHTER, DG
    PONDER, KP
    RETTINGER, SD
    KENNEDY, SC
    FLYE, MW
    TRANSPLANTATION PROCEEDINGS, 1994, 26 (06) : 3379 - 3380
  • [5] Minimal change disease in a patient receiving IFN-α therapy for chronic hepatitis C virus infection
    Dizer, U
    Beker, CM
    Yavuz, I
    Ortatatli, M
    Ozguven, V
    Pahsa, A
    JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2003, 23 (01): : 51 - 54
  • [6] Early prediction and mechanism of the Ribavirin/IFN-α dual therapy effect on chronic hepatitis C virus (HCV) infection.
    Neumann, AU
    Dahari, H
    Conrad, A
    Pianko, S
    McHutchinson, JG
    HEPATOLOGY, 1999, 30 (04) : 309A - 309A
  • [7] Association of serum IFN-λ3 with inflammatory and fibrosis markers in patients with chronic hepatitis C virus infection
    Aoki, Yoshihiko
    Sugiyama, Masaya
    Murata, Kazumoto
    Yoshio, Sachiyo
    Kurosaki, Masayuki
    Hashimoto, Satoru
    Yatsuhashi, Hiroshi
    Nomura, Hideyuki
    Kang, Jong-Hon
    Takeda, Tsutomu
    Naito, Shigeko
    Kimura, Tatsuji
    Yamagiwa, Yoko
    Korenaga, Masaaki
    Imamura, Masatoshi
    Masaki, Naohiko
    Izumi, Namiki
    Kage, Masayoshi
    Mizokami, Masashi
    Kanto, Tatsuya
    JOURNAL OF GASTROENTEROLOGY, 2015, 50 (08) : 894 - 902
  • [8] Association of serum IFN-λ3 with inflammatory and fibrosis markers in patients with chronic hepatitis C virus infection
    Yoshihiko Aoki
    Masaya Sugiyama
    Kazumoto Murata
    Sachiyo Yoshio
    Masayuki Kurosaki
    Satoru Hashimoto
    Hiroshi Yatsuhashi
    Hideyuki Nomura
    Jong-Hon Kang
    Tsutomu Takeda
    Shigeko Naito
    Tatsuji Kimura
    Yoko Yamagiwa
    Masaaki Korenaga
    Masatoshi Imamura
    Naohiko Masaki
    Namiki Izumi
    Masayoshi Kage
    Masashi Mizokami
    Tatsuya Kanto
    Journal of Gastroenterology, 2015, 50 : 894 - 902
  • [9] IFN-Γ ameliorates hepatic fibrosis in chronic hepatitis B virus infection.
    Dooley, S
    Wang, BE
    Jia, JD
    Wu, WF
    Xian, JZ
    Mertens, PR
    Cai, WM
    Weng, HL
    ALCOHOL-CLINICAL AND EXPERIMENTAL RESEARCH, 2004, 28 (08): : 33A - 33A
  • [10] Host liver gene regulation during chronic infection with the hepatitis C virus
    Choi, YH
    Hemby, SE
    Fried, MW
    Hagedorn, CH
    GASTROENTEROLOGY, 2001, 120 (05) : A553 - A554
12345